No Detail Found!

Comparison of nalbuphine with dexmedetomidine for postoperative analgesia in patients undergoing laparoscopic cholecystectomy

Author(s)
Ayesha Shahid Department of Anesthesia, Rawal Institute of Health Sciences, Islamabad, Pakistan
Salman Maqbool Department of Anesthesia, Rawal Institute of Health Sciences, Islamabad, Pakistan
Sidra shabbier Department of Anesthesia, Rawal Institute of Health Sciences, Islamabad, Pakistan
Abstract
Objective: To compare Nalbuphine with Dexmedetomidine for postoperative analgesia in laparoscopic cholecystectomy. Methodology: This study was done at Anesthesia Department, Rawal Institute of Health Sciences Islamabad from 15th April 2019 to 30th Sept 2019. Sixty patients (30 in each group) with age 20 - 60 years having ASA10 physical status class I, II, undergoing elective laparoscopic cholecystectomy were included. Group-A, patients were given injection Nalbuphine 0.1 mg/kg at induction of anesthesia and group B patients were given injection Dexmedetomidine 1 µg/kg 15 min before induction. After premedication with injection Midazolam 2 mg I/V and inj. ondansetron 4mg I/Induction of anesthesia was done with injection Propofol 2 mg/kg. Injection paracetamol 1 gm was given intravenously in all patients. Anesthesia was maintained by mixture of 50% nitrous oxide in oxygen and 2% sevoflurane. Injection cisatracuium 20 µg/kg was used for maintenance of muscle relaxation. Standard hemodynamic monitoring was done intraoperatively. At the end of surgery, residual neuromuscular blockade was reversed by injection neostigmine 30 µg/kg along with atropine 15 µg/kg intravenously. Patients were extubated and monitored in recovery room and were followed postoperatively for onset of pain (VAS used for assessment) and total analgesic requirement in 24-hours (in equivalent doses of morphine) post-operative nausea vomiting, sedation score and shivering. Statistical analysis was done by SPSS 21. Results: There was no statistically significant difference in demographic profile, intraoperative hemodynamic parameters in two groups except for post extubation phase when a sudden rise was observed in HR and BP in Nalbuphine group. There was statistically significant difference in postoperative onset of pain (279/734 minutes with p value 0.000), VAS score (6.6/3.07 with p-value 0.000), 24 hour analgesic requirement in equivalent dose of morphine (17/10 mg with p value 0.000), sedation score (p value 0.000), postoperative shivering (63.3% versus 16.7% with p value 0.000) and postoperative vomiting (70% versus 20% with p value 0.000) in both groups A and B, respectively. However, no difference was observed in incidence of hypotension (6.7% versus 3.3% with p value 0.554). Conclusion: Dexmedetomidine is better analgesic than Nalbuphine for postoperative pain in patients undergoing laparoscopic cholecystectomy
Publication Details
Page(s) 624-628
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 47, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Laparoscopic cholecystectomy, Nalbuphine, dexmedetomidine.
0

Citations

0

Downloads

79

Views